More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

CYP Receives Notice of Acceptance from Aust Patent Office

Jan 6, 2019 at 10:52 PM EST · Issued by Cynata Therapeutics Limited

Filed with ASX · Jan 6, 2019 at 10:52 PM EST · 2 pages · English

On 6ix: 6ix.com/news/cyp-receives-notice-of-acceptance-from-aust-patent-office

Cynata Therapeutics Limited on 6ix

Story so far

  • CYP Receives Notice of Allowance from European Patent OfficeNov 7, 2018
  • Notice of Allowance from EPO for Patent ApplicationMay 7, 2018
  • Notice of Annual General Meeting/Proxy FormOct 9, 2017

Earlier from Cynata Therapeutics

  • Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHDDec 18, 2018
  • Cynata Completes Clinical Study Report in GvHDDec 17, 2018
  • NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with OsteoarthritisDec 13, 2018
  • NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCsDec 12, 2018
  • Cynata Receives $1.3m R&D Tax Incentive RefundNov 18, 2018

Later from Cynata Therapeutics

  • December 2018 Quarterly ReportJan 29, 2019
  • Cynata Receives Favourable Advice on Planned CLI TrialMar 11, 2019
  • Cynata Extends FUJIFILM Licence Option in GvHDMar 20, 2019
  • March 2019 Quarterly ReportApr 26, 2019
  • Cynata Strengthens Board & Executive Management TeamMay 19, 2019
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer